08.10.2012 • News

Abend New CEO at Kolb

Effective 1 October 2012, Dr. Sven Abend took over the role as CEO with Kolb. He is replacing Peter Wilkes.

Sven Abend joined Kolb in 2010 as Business Manager for one of the business lines. Since then, his responsibility increased step-wise and with that, Sven was able to get a broader and deeper understanding of Kolb, the markets and its customers.

Next to strengthening the portfolio, it will be Sven's role to continue developing the relationship with KLK.

Kolb is one of the largest alkoxylators in Europe. The company with its headquarters in Switzerland has a presence.

 

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read